1. From the Section of Medical Oncology, Yale University School of Medicine, New Haven, CT; the Section of Immunobiology, Yale University School of Medicine, New Haven, CT; the Section of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia; the Department of Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia; and the Department of Biochemistry and Molecular Biology, University of Massachusetts, Amherst.